Valencia, Valencian Community, Spain In 2007 was created Realiza Business Angels, which is appeared as Corporate Investor. The main office of represented Corporate Investor is situated in the Valencia. The venture was found in Europe in Spain.
The typical case for the fund is to invest in rounds with 1-2 participants. Despite the Realiza Business Angels, startups are often financed by Faraday Venture Partners, Toubkal Partners, Lysosomal Therapeutics. The meaningful sponsors for the fund in investment in the same round are Plug and Play, Nauta Capital, Fundacion Innovacion Bankinter. In the next rounds fund is usually obtained by Nauta Capital, Sonae IM, Lysosomal Therapeutics.
The fund was created by Lucas Martinez, Santiago Reyna, Tomas Guillen Gorbe. Besides them, we counted 2 critical employees of this fund in our database.
Opposing the other organizations, this Realiza Business Angels works on 18 percentage points less the average amount of lead investments. The important activity for fund was in 2014. The increased amount of exits for fund were in 2017. Deals in the range of 100 thousands - 1 million dollars are the general things for fund. Considering the real fund results, this Corporate Investor is 14 percentage points less often commits exit comparing to other organizations. The fund is constantly included in less than 2 investment rounds annually.
We can highlight the next thriving fund investment areas, such as Therapeutics, Apps. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Spain. Among the most popular portfolio startups of the fund, we may highlight Nextail, Artax Biopharma, Universal Diagnostics SL. The fund has no exact preference in some founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Anhui Zhongding Sealing Parts | Anhui, China, Ningguo |
| Birdflight Investments Ltd | - |
| Daintree.VC | England, London, United Kingdom |
| Eminence Ventures | China, Shanghai |
| Foundation Holdings | Dubai, United Arab Emirates |
| Her Capital | - |
| Holman Growth Ventures | Pennsylvania, Philadelphia, United States |
| IT Ventures | England, London, United Kingdom |
| Jiale Capital | China, Jiangsu, Nantong |
| Jieshi Investment | - |
| Orlando Healthcare Ventures | - |
| Royalty Pharma | New York, New York, United States |
| RSL | - |
| Rubio Impact Ventures | Amsterdam, Noord-Holland, The Netherlands |
| Source Interlink Companies | Bonita Springs, Florida, United States |
| Tank Partners | Seguin, Texas, United States |
| Xiamen Qingwa Juncheng Venture Capital | China, Fujian, Xiamen |
| ZORA Ventures | Israel, Tel Aviv, Tel Aviv District |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Nextail | $1M | 08 Sep 2016 | Community of Madrid | ||
Artax Biopharma | $2M | 12 Oct 2014 | Cambridge, Massachusetts, United States | ||
Beroomers | $236K | 07 May 2014 | Valencia, Valencian Community, Spain | ||
Jugo | $177K | 14 Apr 2013 | Madrid, Community of Madrid, Spain | ||
Imegen | $708K | 01 Sep 2009 | Spain, Valencian Community, Spain |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Nextail | $1M | 08 Sep 2016 | Community of Madrid | ||
Artax Biopharma | $2M | 12 Oct 2014 | Cambridge, Massachusetts, United States | ||
Beroomers | $236K | 07 May 2014 | Valencia, Valencian Community, Spain | ||
Jugo | $177K | 14 Apr 2013 | Madrid, Community of Madrid, Spain | ||
Imegen | $708K | 01 Sep 2009 | Spain, Valencian Community, Spain |
